Document Detail

Effects of saponins from Herniaria glabra on blood pressure and renal function in spontaneously hypertensive rats.
MedLine Citation:
PMID:  10709449     Owner:  NLM     Status:  MEDLINE    
Experiments were performed on male and female spontaneously hypertensive rats weighing 310-340 g (10 animals per group). The oral administration of 200 mg/kg/day of saponins from Herniaria glabra for 30 days, resulted in a significant decrease in blood pressure in hypertensive rats. The systolic and diastolic blood pressure decreased significantly and respectively from 187.60 +/- 20.63/119.00 +/- 7.09 mmHg at day 0 (D0) to 141.60 +/- 7.51/90.40 +/- 7.68 mmHg at day 30 (D30), p < 0.001 (vs. 186.30 +/- 11.27/114.10 +/- 12.00 mm Hg at D0 to 154.50 +/- 6.38/132.3 +/- 7.68 mmHg at D30 in furosemide-treated group, p < 0.001). Control animals receiving placebo did not show any significant variation in the mean arterial pressure. The effect of saponins of Herniaria glabra on renal function was evaluated in spontaneously hypertensive rats using clearance techniques. Glomerular filtration rate was constant in the control rats and increased significantly in the hypertensive rats after saponins treatment (5.55 +/- 0.32 vs. 6.03 +/- 0.43 in the control (C) and saponins (S) groups, respectively, p < 0.05). Saponins administration provoked an increase in urinary flow (59.38 +/- 5.85 h-1 vs. 36.92 +/- 5.17 h-1, p < 0.001). Saponins also increased potassium excretion (6.89 +/- 0.81 h-1 vs. 5.40 +/- 0.51 h-1, p < 0.001) and sodium excretion (10.74 +/- 1.21 h-1 vs. 7.25 +/- 0.54 h-1, p < 0.001) as well as chloride excretion (13.59 +/- 1.04 mmol. kg-1.24 h-1 vs. 9.67 +/- 0.77 h-1, p < 0.001). It is concluded that chronic oral administration of saponins from Herniaria glabra decreased the arterial blood pressure and affected salt and water transport in renal tubules.
H Rhiouani; A Settaf; B Lyoussi; Y Cherrah; M A Lacaille-Dubois; M Hassar
Related Documents :
10490899 - Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous me...
11979329 - Effect of apomorphine on intracavernous pressure and blood pressure in conscious, spina...
2523659 - Antitrophic properties of antihypertensive drugs may depend solely on their blood press...
9922389 - Two blood pressure/cardiac mass quantitative trait loci on chromosome 3 in dahl rats.
22285459 - Mobile wearable device for long term monitoring of vital signs.
25203399 - Research into fabrics used in compression therapy and assessment of their impact on tre...
18641799 - The effects of positive end-expiratory pressure in alveolar recruitment during mechanic...
1600639 - Hypoxic attenuation of brain stem serotonin does not influence sodium-induced hypertens...
7352119 - Management of pressure sores. comparative study in medical and surgical patients.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Thérapie     Volume:  54     ISSN:  0040-5957     ISO Abbreviation:  Therapie     Publication Date:    1999 Nov-Dec
Date Detail:
Created Date:  2000-04-14     Completed Date:  2000-04-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0420544     Medline TA:  Therapie     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  735-9     Citation Subset:  IM    
Department of Biology, Faculty of Science D.M., Fez, Morocco.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects
Diuresis / drug effects
Drug Evaluation, Preclinical
Glomerular Filtration Rate / drug effects
Hypertension / drug therapy*
Kidney / drug effects*
Natriuresis / drug effects
Plants, Medicinal / chemistry*
Rats, Inbred SHR
Saponins / isolation & purification,  pharmacology,  therapeutic use*
Reg. No./Substance:
0/Saponins; 54-31-9/Furosemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antibacterial and antifungal activities of Cistus incanus and C. monspeliensis leaf extracts.
Next Document:  Update of a database on plants involved in the composition of 825 drugs: Pharmaplantes-Kénitra 98